Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Knowledge Measurement Is Coming | Main | NeuroWiki, Really. »

August 3, 2004

The Future of Hearing (Neuroelectronics and Audioceuticals)

Email This Entry

Posted by Zack Lynch

Don't miss the next Bay Area Future Salon on August 12th, where Dr. Mike Chorost, SRI International, and my brother, Dr. Eric Lynch, Sound Pharmaceuticals, will discuss the present state of neural technologies for treating deafness and their likely future. Dr. Chorost will open by explaining how the most advanced neurostimulation technology on the market, the cochlear implant, enables the deaf to hear. Dr. Lynch will follow with a discussion of audioceutical technologies may actually prevent and cure deafness.

Where: Thursday 12th of August. SAP Labs North America, Building D, Room Southern Cross, 3410 Hillview Avenue, Palo Alto, CA 94304. 7pm.

Comments (0) + TrackBacks (0) | Category: Neuropharma



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
NIO Unveils Top 10 Neuroscience Trends for 2009
NIO CEO Media Tour in NYC Gets Results
O Neurocaster
Manuscript Sent to Japan
2009 Stem Cell Trendsetters in Neurology and Psychiatry
Mental Health Parity Legislation Passes within Financial Package
Holy Neurofinancial Meltdown Bernanke
Interest in Neuropolicy Grows